Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Patient-centered Care01:13

Patient-centered Care

3.1K
Patient-centered care involves delivering care beyond inpatient hospitalization. Reflective practice can enhance a patient-centered approach. Reflective practice is a process of reasoning that considers all aspects of the present situation, including practicalities, learning from personal practice, and consideration of patient needs. Patients appreciate care decisions made while considering their input. Involving the patient in their care provides the patient with a sense of contribution rather...
3.1K
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

278
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
278
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

269
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
269
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

241
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
241
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

277
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
277
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

334
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
334

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Search for Axion Dark Matter from 1.1 to 1.3 GHz with ADMX.

Physical review letters·2025
Same author

The WFH Guidelines for the Management of Haemophilia: AAV Gene Therapy, 2025.

Haemophilia : the official journal of the World Federation of Hemophilia·2025
Same author

The Critical Need to Consolidate All Gene Therapy Data in Haemophilia.

Haemophilia : the official journal of the World Federation of Hemophilia·2025
Same author

Spinal Stenosis: An Emerging Complication of Ageing in People With Haemophilia.

Haemophilia : the official journal of the World Federation of Hemophilia·2025
Same author

ADMX Axion Dark Matter Bounds around 3.3  μeV with Dine-Fischler-Srednicki-Zhitnitsky Discovery Ability.

Physical review letters·2025
Same author

Test-retest reliability of a mobile application of the patient reported outcomes burdens and experiences (PROBE) study.

Haemophilia : the official journal of the World Federation of Hemophilia·2024
Same journal

Clinical Factors for Predicting Synovial Hypertrophy in Early Haemophilic Arthropathy on Prophylaxis: A Cross-Sectional Study of Patient- and Joint-Level Analyses Using Musculoskeletal Ultrasound.

Haemophilia : the official journal of the World Federation of Hemophilia·2026
Same journal

Utilisation and Perceived Value of Genetic Counsellors Within US Haemophilia Treatment Centres.

Haemophilia : the official journal of the World Federation of Hemophilia·2026
Same journal

Correction to "Reference Values for the Haemophilia Joint Health Score in Patients With Severe Haemophilia Derived From the Canadian Bleeding Disorder Registry".

Haemophilia : the official journal of the World Federation of Hemophilia·2026
Same journal

Monitoring of Coagulation Potential of Efanesoctocog Alfa in Haemophilia A: Insights From Conventional and Global Hemostasis Assays.

Haemophilia : the official journal of the World Federation of Hemophilia·2026
Same journal

Perceived Barriers to Healthcare Access Among Paediatric Patients With Haemophilia in Cambodia: A Cross-Sectional Survey.

Haemophilia : the official journal of the World Federation of Hemophilia·2026
Same journal

Management of Breakthrough Bleeding During Emicizumab Prophylaxis in Acquired Haemophilia A: Data From the GTH-AHA-EMI Study.

Haemophilia : the official journal of the World Federation of Hemophilia·2026
See all related articles

Related Experiment Video

Updated: Feb 12, 2026

Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients
03:47

Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients

Published on: July 12, 2024

1.2K

Patient-centred value framework for haemophilia.

B O'Mahony1, G Dolan2, D Nugent3

  • 1Irish Haemophilia Society, Trinity College, Dublin, Ireland.

Haemophilia : the Official Journal of the World Federation of Hemophilia
|April 8, 2018
PubMed
Summary
This summary is machine-generated.

A new framework defines patient-centered value in haemophilia care, organizing outcomes to guide healthcare decisions. This approach ensures comprehensive assessment beyond traditional metrics for rare disease management.

Keywords:
haemophiliaoutcomesquality of lifevalue

More Related Videos

Synthesis and Characterization of Functionalized Metal-organic Frameworks
11:27

Synthesis and Characterization of Functionalized Metal-organic Frameworks

Published on: September 5, 2014

49.2K
Watershed Planning within a Quantitative Scenario Analysis Framework
12:44

Watershed Planning within a Quantitative Scenario Analysis Framework

Published on: July 24, 2016

8.7K

Related Experiment Videos

Last Updated: Feb 12, 2026

Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients
03:47

Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients

Published on: July 12, 2024

1.2K
Synthesis and Characterization of Functionalized Metal-organic Frameworks
11:27

Synthesis and Characterization of Functionalized Metal-organic Frameworks

Published on: September 5, 2014

49.2K
Watershed Planning within a Quantitative Scenario Analysis Framework
12:44

Watershed Planning within a Quantitative Scenario Analysis Framework

Published on: July 24, 2016

8.7K

Area of Science:

  • Medical Research
  • Health Economics
  • Patient-Reported Outcomes

Background:

  • Increasing healthcare costs necessitate objective evaluation of rare disease treatments.
  • The haemophilia community seeks standardized measures for patient-centered value in care.
  • Current healthcare spending scrutiny requires a defined value assessment for haemophilia.

Purpose of the Study:

  • To establish a globally applicable, patient-centered outcomes framework for assessing value in haemophilia healthcare.
  • To develop a structured approach for evaluating the multifaceted impact of haemophilia care on patients.
  • To create a tool for consistent and objective value assessment in haemophilia treatment.

Main Methods:

  • Convened an international, multidisciplinary expert panel.
  • Utilized Porter's value-based healthcare model.
  • Organized identified patient impacts into a three-tiered outcomes framework.

Main Results:

  • Tier 1 (Health Status): Includes bleeding frequency, musculoskeletal health, life-threatening bleeds, and functional measures.
  • Tier 2 (Process of Recovery): Encompasses time to treatment/recovery, missed work/education, and care disutilities like inhibitor development.
  • Tier 3 (Sustainability of Health): Focuses on bleed avoidance, long-term productivity, and mitigating risks of inadequate therapy or age-related complications.

Conclusions:

  • Haemophilia care impacts diverse patient-centered outcomes across various systems.
  • The developed framework aids value-based decision-making for stakeholders.
  • This outcomes framework provides a foundation for a standardized set of measures in haemophilia care.